Get App
Download App Scanner
Scan to Download
Advertisement

Indostar Capital Finance Shares in Focus as Motilal Oswal Sees Strong FY28 Runway — Check Target Price

Indostar Capital Finance appears to be at an inflection point where earlier structural tightening is now translating into improved growth visibility and stronger portfolio outcomes.

Indostar Capital Finance Shares in Focus as Motilal Oswal Sees Strong FY28 Runway — Check Target Price
The combination of better underwriting, declining cost of funds, and operating discipline is creating a more stable earnings base for Indostar Capital.
(Photo: Radhakisan Raswe/ NDTV Profit)
STOCKS IN THIS STORY
Indostar Capital Finance Ltd.
--

NDTV Profit's special research section collates quality and in-depth equity and economy research reports from across India's top brokerages, asset managers and research agencies. These reports offer NDTV Profit's subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Motilal Oswal Report

Indostar Capital Finance Ltd. appears to be at an inflection point where earlier structural tightening is now translating into improved growth visibility and stronger portfolio outcomes.

The combination of better underwriting, declining cost of funds, and operating discipline is creating a more stable earnings base.

With execution gaining consistency, the medium-term trajectory looks more predictable and scalable. This provides a clearer foundation for sustained performance as the business moves into its next phase of expansion.

Motilal Oswal estimates a compound annual growth rate of 23%/36% in assets under management/ pro-provision operating profit over FY26-28, supported by net interest income improvement to 11.1%/12% in FY27E/FY28E.

The brokerage reiterates Buy with a target price of Rs 270 (based on 0.9 times FY28E book value per share), implying a potential upside of 24%.

Click on the attachment to read the full report:

Motilal Oswal Indostar Update.pdf
VIEW DOCUMENT

ALSO READ: Sun Pharma to Dr. Redddy's: Healthcare Stocks to Watch Ahead of Q4 Results, Cipla Among Systematix Top Picks

DISCLAIMER

This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.

To continue reading this story
You must be an existing Premium User

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search
Add NDTV Profit As Google Preferred Source
Loading PDF...